"QANDLI DIABET BILAN OG‘RIGAN BEMORLARDA GLYUKOZA MONITORINGI VA UNING TURMUSH SIFATIGA TA’SIRI"

Article Sidebar

PDF (Русский)
Issue: Vol. 4 No. 2 : Innovative research in the modern world: theory and practice
Section: Articles
Published:

Main Article Content

Endokrinolog shifokor Navoiy viloyat endokrinologiya dispanseri,Navoiy sh,O`zbekiston
Djuz2302@gmail.com
Endokrinolog shifokor Navoiy viloyat endokrinologiya dispanseri,Navoiy sh,O`zbekiston
Djuz2302@gmail.com
Reanimatolog shifokor Navoiy viloyat endokrinologiya dispanseri,Navoiy sh,O`zbekiston
Djuz2302@gmail.com

Abstract:

Qandli diabet (QD) dunyo bo‘ylab surunkali kasalliklar orasida eng keng tarqalganlardan biri hisoblanadi. Kasallikning asosiy xususiyati glyukoza darajasining boshqaruvdan chiqishi bo‘lib, bu ko‘plab asoratlar, jumladan, kardiovaskulyar, buyrak va ko‘z kasalliklariga olib keladi[1]. Bemorlarning glyukoza darajasini o‘z vaqtida monitoring qilishi va uni boshqarishi kasallik oqibatlarini yengillashtirish hamda hayot sifatini yaxshilashning asosiy omili hisoblanadi [2]. Hozirgi kunda glyukoza monitoringi uchun turli texnologik usullar, jumladan, invaziv va noinvaziv texnologiyalar qo‘llanilmoqda. Ushbu texnologiyalar nafaqat glyukoza darajasini real vaqt rejimida kuzatish, balki bemorlarning turmush sifatini oshirishda muhim rol o‘ynaydi [3]. Biroq, ushbu monitoring tizimlarining samaradorligi, qulayligi va iqtisodiy jihatlari bo‘yicha o‘rganishlar yetarli emas.

Article Details

How to Cite:

Qurbonov, X. ., Mardonova , D. ., & Uzakov, D. (2025). "QANDLI DIABET BILAN OG‘RIGAN BEMORLARDA GLYUKOZA MONITORINGI VA UNING TURMUSH SIFATIGA TA’SIRI". Universal Index Library of Innovative Research in the Modern World: Theory and Practice, 4(2), 100–101. Retrieved from https://lib.uniconflix.com/index.php/uilzdit/article/view/43641

References:

Daneman, D. (2006). Type 1 diabetes. The Lancet, 367(9513), 847-858.

Nathan, D. M., & DCCT/EDIC Research Group. (2014). The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 years: Overview. Diabetes Care, 37(1), 9-16.

Bergenstal, R. M., et al. (2010). Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. The New England Journal of Medicine, 363(4), 311-320.

Laffel, L. M., et al. (2003). Continuous glucose monitoring in diabetic patients. Diabetes Care, 26(5), 1551-1556.

Polonsky, W. H., & Fisher, L. (2015). Emotional and quality-of-life aspects of diabetes management. Current Diabetes Reports, 15(8), 70.